Published in Radiology on January 31, 2007
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Magnetic particle imaging with tailored iron oxide nanoparticle tracers. IEEE Trans Med Imaging (2014) 1.91
Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis. Clin J Am Soc Nephrol (2008) 1.87
MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol (2010) 1.78
Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant (2008) 1.74
Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol (2008) 1.71
New magnetic resonance imaging methods in nephrology. Kidney Int (2013) 1.60
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol (2008) 1.55
Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging (2007) 1.53
Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. Radiology (2009) 1.52
Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging (2008) 1.48
Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography. Magn Reson Med (2009) 1.42
A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging. Quant Imaging Med Surg (2017) 1.38
MR angiography with blood pool contrast agents. Eur Radiol (2007) 1.28
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology (2010) 1.26
Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian J Dermatol (2011) 1.21
Magnetic particle imaging (MPI) for NMR and MRI researchers. J Magn Reson (2012) 1.19
Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion. J Cereb Blood Flow Metab (2009) 1.19
How Can New Imaging Modalities Help in the Practice of Radiology? Eurasian J Med (2016) 1.18
CKD as an underrecognized threat to patient safety. Am J Kidney Dis (2009) 1.14
Arterial spin-labeled MR perfusion imaging: clinical applications. Magn Reson Imaging Clin N Am (2009) 1.13
Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases. Eur Radiol (2009) 1.13
Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images. Magn Reson Med (2009) 1.11
Functional assessment of the kidney from magnetic resonance and computed tomography renography: impulse retention approach to a multicompartment model. Magn Reson Med (2008) 1.11
ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol (2007) 1.11
Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson (2011) 1.10
Renal arteries: isotropic, high-spatial-resolution, unenhanced MR angiography with three-dimensional radial phase contrast. Radiology (2010) 1.08
Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J Magn Reson Imaging (2010) 1.06
MR fluoroscopy in vascular and cardiac interventions (review). Int J Cardiovasc Imaging (2011) 1.04
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol (2008) 1.04
Linearity and shift invariance for quantitative magnetic particle imaging. IEEE Trans Med Imaging (2013) 1.01
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med (2008) 1.00
Simultaneous noncontrast angiography and intraplaque hemorrhage (SNAP) imaging for carotid atherosclerotic disease evaluation. Magn Reson Med (2012) 0.98
Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography. Biomacromolecules (2008) 0.97
Quantification of renal allograft perfusion using arterial spin labeling MRI: initial results. Eur Radiol (2009) 0.96
Estimates of glomerular filtration rate from MR renography and tracer kinetic models. J Magn Reson Imaging (2009) 0.96
Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. AJR Am J Roentgenol (2011) 0.96
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol (2010) 0.96
Comparison of nonenhanced MR angiographic subtraction techniques for infragenual arteries at 1.5 T: a preliminary study. Radiology (2013) 0.95
Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 0.95
Integrating carthage-specific T1rho MRI into knee clinic diagnostic imaging. Iowa Orthop J (2011) 0.94
Tuberculosis of the genitourinary system-Urinary tract tuberculosis: Renal tuberculosis-Part II. Indian J Radiol Imaging (2013) 0.94
Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging (2007) 0.94
Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines. Insights Imaging (2015) 0.94
Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience. Acad Radiol (2009) 0.93
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? MAGMA (2007) 0.93
Assessment of renal function with dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am (2008) 0.92
Unenhanced calf MR angiography at 3.0 T using electrocardiography-gated partial-fourier fast spin echo imaging with variable flip angle. Eur Radiol (2010) 0.92
Nephrogenic systemic fibrosis. Pediatr Radiol (2007) 0.90
Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. J Clin Invest (2015) 0.89
Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions. Radiology (2012) 0.88
Intra-operative 3-T MRI for paediatric brain tumours: challenges and perspectives. Pediatr Radiol (2012) 0.87
Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol (2007) 0.87
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review. Eur Radiol (2010) 0.86
Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol (2008) 0.86
Non-contrast-enhanced 4D MR angiography with STAR spin labeling and variable flip angle sampling: a feasibility study for the assessment of Dural Arteriovenous Fistula. Neuroradiology (2014) 0.86
Isolated periaortitis: clinical and imaging characteristics. Vasc Health Risk Manag (2007) 0.86
Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. Br J Radiol (2010) 0.85
Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol (2012) 0.85
Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis. J Immunol (2012) 0.84
Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials. Eur Radiol (2008) 0.84
Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine. J Comput Assist Tomogr (2009) 0.83
Current status and future perspectives of magnetic resonance high-field imaging: a summary. Neuroimaging Clin N Am (2012) 0.83
Are Non-contrast MR Images enough for Detection of Fracture Levels Prior to Percutaneous Vertebroplasty in Patients with Osteoporosis? Interv Neuroradiol (2009) 0.82
Gd-DOTA administration at MRI in children younger than 18 months of age: immediate adverse reactions. Pediatr Radiol (2011) 0.82
Fast inversion recovery magnetic resonance angiography of the intracranial arteries. Magn Reson Med (2010) 0.82
Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson (2012) 0.82
A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology (2015) 0.82
Classification of breast lesions pre-contrast injection using water resonance lineshape analysis. NMR Biomed (2012) 0.82
Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function. Acad Radiol (2012) 0.82
Diffusion-weighted imaging of the liver: an update. Cancer Imaging (2013) 0.82
Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children. Pediatr Radiol (2009) 0.81
Challenges associated with peripheral arterial disease in women. Vasc Health Risk Manag (2014) 0.81
Nephrogenic systemic fibrosis: a concise review for cardiologists. Tex Heart Inst J (2010) 0.81
Nephrogenic systemic fibrosis in liver disease: a systematic review. J Magn Reson Imaging (2009) 0.81
Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature. Skeletal Radiol (2008) 0.81
The association of predonation hypertension with glomerular function and number in older living kidney donors. J Am Soc Nephrol (2014) 0.81
Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol (2013) 0.81
Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles. Magn Reson Med (2013) 0.80
Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging? PLoS One (2015) 0.80
Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents. Eur Radiol (2009) 0.80
Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord (2013) 0.80
Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting. J Cardiovasc Magn Reson (2008) 0.79
Non-ECG-gated unenhanced MRA of the carotids: optimization and clinical feasibility. Eur Radiol (2013) 0.79
Gadofosveset-enhanced MR angiography of the pedal arteries in patients with diabetes mellitus and comparison with selective intraarterial DSA. Eur Radiol (2009) 0.79
Nephrogenic systemic fibrosis risk and liver disease. Int J Nephrol (2014) 0.79
Peripheral contrast-enhanced MR angiography at 3.0T, improved spatial resolution and low dose contrast: initial clinical experience. Eur Radiol (2008) 0.79
Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis? Radiology (2007) 0.79
Non-contrast enhanced 3D SSFP MRA of the renal allograft vasculature: a comparison between radial linear combination and Cartesian inflow-weighted acquisitions. Magn Reson Imaging (2013) 0.79
Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation. J Magn Reson Imaging (2014) 0.78
Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis. Cancer Imaging (2014) 0.78
Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation. Histochem Cell Biol (2010) 0.78
Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS One (2015) 0.78
Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population. World J Clin Pediatr (2016) 0.78
Computed tomography enterography and magnetic resonance enterography: the future of small bowel imaging. Clin Colon Rectal Surg (2008) 0.77
Application of FT-based MMSE deconvolution method for cerebral blood flow measurement in patients with leukoaraiosis. Magn Reson Imaging (2009) 0.77
A comparison of 4D time-resolved MRA with keyhole and 3D time-of-flight MRA at 3.0 T for the evaluation of cerebral aneurysms. BMC Neurol (2012) 0.77
Current techniques for assessment of upper extremity vasculature prior to hemodialysis vascular access creation. Eur Radiol (2007) 0.77
Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology (2006) 2.35
Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Kidney Int (2013) 2.12
C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. Transplantation (2015) 1.50
Tubular expression of heat-shock protein 27 inhibits fibrogenesis in obstructive nephropathy. Kidney Int (2012) 1.50
Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Nephrol Dial Transplant (2005) 1.48
Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int (2014) 1.38
Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience. Radiology (2005) 1.27
Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging (2010) 1.17
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) (2008) 1.15
Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair (2012) 1.13
HSP27 is involved in the pathogenesis of kidney tubulointerstitial fibrosis. Am J Physiol Renal Physiol (2008) 1.11
Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys. Magn Reson Imaging (2009) 1.06
Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am J Physiol Renal Physiol (2007) 1.03
Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. Clin Transplant (2013) 1.02
The rationale, implementation, and effect of the Medicare CKD education benefit. Am J Kidney Dis (2011) 0.99
Bisphosphonates and bone fractures in long-term kidney transplant recipients. Transplantation (2008) 0.96
Comparing kidney perfusion using noncontrast arterial spin labeling MRI and microsphere methods in an interventional swine model. Invest Radiol (2011) 0.95
Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience. Acad Radiol (2009) 0.93
CKD stage-to-stage progression in native and transplant kidney disease. Nephrol Dial Transplant (2007) 0.90
Measurement and comparison of T1 relaxation times in native and transplanted kidney cortex and medulla. J Magn Reson Imaging (2011) 0.89
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest (2014) 0.89
Drug insight: maintenance immunosuppression in kidney transplant recipients. Nat Clin Pract Nephrol (2006) 0.88
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am J Kidney Dis (2008) 0.88
A case series of real-time hemodynamic assessment of high output heart failure as a complication of arteriovenous access in dialysis patients. Semin Dial (2014) 0.87
Luminex-based desensitization protocols: the University of Wisconsin initial experience. Transplantation (2011) 0.86
Reproducibility of renal perfusion MR imaging in native and transplanted kidneys using non-contrast arterial spin labeling. J Magn Reson Imaging (2011) 0.86
Update on nephrogenic systemic fibrosis: are we making progress? Int J Dermatol (2011) 0.86
Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation (2010) 0.86
Serum HSP27 is associated with medullary perfusion in kidney allografts. J Nephrol (2012) 0.84
"Venopathy" at work: recasting neointimal hyperplasia in a new light. Transl Res (2010) 0.84
MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function. Nephrol Dial Transplant (2011) 0.84
Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation (2014) 0.83
The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model. Fibrogenesis Tissue Repair (2010) 0.83
Posttransplant anemia: the role of sirolimus. Kidney Int (2009) 0.83
Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. Transplantation (2014) 0.81
ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro. Kidney Int (2005) 0.81
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
C4d-positive acute antibody-mediated rejection due to anti-HLA-DP antibody: a tale of one patient and a review of the University of Wisconsin experience. Clin Transpl (2006) 0.80
Contributing factors to complications and surgical success in mouse kidney transplantation. Int Braz J Urol (2012) 0.80
Left atrial volume is associated with inflammation and atherosclerosis in patients with kidney disease. Echocardiography (2008) 0.80
Mitral annular calcification is associated with reduced left ventricular function and inflammation in patients with chronic kidney disease. J Am Soc Echocardiogr (2008) 0.80
Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers. Pharmacol Res (2011) 0.80
Chronic kidney disease stage progression in liver transplant recipients. Clin J Am Soc Nephrol (2011) 0.80
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation (2016) 0.79
The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience. Clin Transplant (2012) 0.79
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79
A comparison between blood flow outcomes of tunneled external jugular and internal jugular hemodialysis catheters. J Vasc Access (2012) 0.79
The Case | Best not shaken or stirred! Chronic lymphocytic leukemia and hyperkalemia. Kidney Int (2010) 0.79
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79
A Meta-analysis of Stent Placement vs. Angioplasty for Dialysis Vascular Access Stenosis. Semin Dial (2014) 0.78
Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD staging. Am J Kidney Dis (2007) 0.78
Do statins delay the incidence of ESRD in diabetic patients with moderate CKD? J Nephrol (2010) 0.77
Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose. Invest Radiol (2013) 0.77
A case report of deferasirox-induced kidney injury and Fanconi syndrome. WMJ (2013) 0.77
Interventional nephrology: Catheter dysfunction--prevention and troubleshooting. Clin J Am Soc Nephrol (2013) 0.77
Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model. Transplantation (2015) 0.76
Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia. J Vasc Access (2014) 0.76
Desensitization across the HLA barrier in kidney transplantaion. Front Biosci (Schol Ed) (2011) 0.76
How I do it: directional atherectomy for in-stent restenosis of a PTFE arteriovenous graft. Semin Dial (2008) 0.76
One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients. J Ren Nutr (2010) 0.75
Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Invest Radiol (2016) 0.75
Chronic total occlusion and successful drug-eluting stent placement in Takayasu arteritis-induced renal artery stenosis. Clin Med Res (2013) 0.75
Longitudinal Assessment of Renal Perfusion and Oxygenation in Transplant Donor-Recipient Pairs Using Arterial Spin Labeling and Blood Oxygen Level-Dependent Magnetic Resonance Imaging. Invest Radiol (2016) 0.75
Sexual concerns among kidney transplant recipients. Clin Transplant (2014) 0.75
Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle? Cutis (2008) 0.75
Stent migration and folding in the subclavian vein during subclavian hemodialysis catheter placement. Semin Dial (2008) 0.75
Post-transplant DSA monitoring may predict antibody-mediated rejection in sensitized kidney transplant recipients. Clin Transpl (2011) 0.75
Renal Function and Transplantation in Liver Disease. Transplantation (2015) 0.75
A single center kidney transplant experience among ten Caucasian females with end-stage renal disease due to scleroderma . Clin Nephrol (2017) 0.75
How I do it: endovascular stent deployment using a novel technique that obviates the need for introducer-sheath upsizing. Semin Dial (2008) 0.75
In Kidney Transplant Recipients With a Positive Virtual Crossmatch, High PRA was Associated With Lower Incidence of Viral Infections. Transplantation (2016) 0.75
Peripheral administration of antithymocyte globulins: a review of current literature. Transplant Rev (Orlando) (2012) 0.75
Development and Psychometric Testing of a Sexual Concerns Questionnaire for Kidney Transplant Recipients. J Nurs Meas (2015) 0.75
Quiz Page July 2013: a man with acute kidney injury and cutaneous purpura. Am J Kidney Dis (2013) 0.75
Incidence and Indications for Late Allograft Pancreatectomy while on Continued Immunosuppression. Transplantation (2016) 0.75
Nonserogroup O1 Vibrio cholerae in a renal transplant patient. Transplantation (2007) 0.75
The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD). Transplantation (2016) 0.75
Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis. J Vasc Access (2014) 0.75